Of the AC isoforms expressed in HEK and hRPT cells (AC3, AC5, AC6, AC7, and AC9), AC5/6 was distributed to a greater extent in LRs than non-LRs in HEK-hD 1 R (84.5 ± 2.3% of total), HEK-hD 5 R (68.9 ± 3.1% of total), and hRPT cells (66.6 ± 2.2% of total) (P b 0.05, n = 4/group). In HEK-hD 1 R cells, the D 1 -like receptor agonist fenoldopam (1μM/15 min) increased AC5/6 protein (+ 17.2 ± 3.9% of control) in LRs but decreased it in non-LRs (−47.3 ± 5.3% of control) (P b 0.05, vs. control, n = 4/group). By contrast, in HEK-hD 5 R cells, fenoldopam increased AC5/6 protein in non-LRs (+67.1±5.3% of control, P b 0.006, vs. control, n = 4) but had no effect in LRs. In hRPT cells, fenoldopam increased AC5/6 in LRs but had little effect in non-LRs. Disruption of LRs with methyl-β-cyclodextrin decreased basal AC activity in HEK-D 1 R (−94.5 ± 2.0% of control) and HEK-D 5 R cells (−87.1 ± 4.6% of control) but increased it in hRPT cells (6.8 ± 0.5-fold). AC6 activity was stimulated to a greater extent by D 1 R than D 5 R, in agreement with the greater colocalization of AC5/6 with D 1 R than D 5 R in LRs. We conclude that LRs are essential not only for the proper membrane distribution and maintenance of AC5/6 activity but also for the regulation of D 1 R-and D 5 R-mediated AC signaling.
Introduction
Adenylyl cyclases (ACs) catalyze the conversion of intracellular ATP to adenosine 3, 5-cyclic monophosphate (cAMP) which mediates the actions of many hormones and neurotransmitters [1] [2] [3] [4] . To date, 10 mammalian ACs have been cloned and characterized [3, 5] . They are grouped into 4 major subfamilies: group 1 is comprised of Ca 2+ -stimulated AC1, AC3, and AC8; group 2 is comprised of Gβγ-stimulated AC2, AC4, and AC7; group 3 is comprised of Ca
2+
-inhibited AC5 and AC6; and group 4 has one member, forskolin-insensitive AC9 [3] [4] [5] . All of these nine ACs are stimulated by the GTP-bound α subunit of G protein [3, 5] . G protein-coupled receptors (GPCRs) regulate AC activity through G protein subunits [6] [7] [8] [9] . However, the tenth AC, a splice variant in the testis (sAC), lacks a membrane spanning domain and is stimulated by calcium but not by G proteins [3, 5] . Each AC isoform has a specific pattern of tissue/organ distribution and a specific pattern of regulation by G proteins, calcium/calmodulin, and protein kinases [1] [2] [3] [4] [5] .
Dopamine receptors are classically divided into two groups: D 1 -and D 2 -like receptors, based on their interaction with AC [6] [7] [8] . The D 1 -like receptors comprised of the D 1 R and D 5 R receptor subtypes stimulate AC through Gαs whereas the D 2 -like receptors comprised of the D 2 , D 3 , and D 4 receptor subtypes inhibit AC [7, 8] . We have reported that all AC mRNAs and proteins are found in the rat kidney except AC1 and AC8. AC isoforms 2, 3, 6, 7, and 9 are expressed in rat renal proximal tubules [9] . These AC isoforms plus AC4 and AC5 are also expressed in the mouse and rat renal collecting duct [10, 11] .
The human D 1 R (hD 1 R), as with other GPCRs, and ACs are regulated by lipid rafts and caveolae [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Lipid rafts are dynamic structures, rich in cholesterol and sphingolipids that are important in organizing signal transduction cascades. Caveolae are a subset of lipid rafts characterized by their invaginated morphology, formed by the crosslinking of their characteristic marker protein, caveolin-1 (Cav-1) [3, 13, 14] . Ca 2+ -sensitive ACs (AC1, AC3, AC5, AC6, and AC8) are found in lipid rafts, while Ca 2+ -insensitive ACs (AC2, AC4, and AC7) are found in non-lipid rafts [4, 14] . The association of GPCRs with specific AC isoforms has been reported. AC5 and AC6 are associated with: β 2 adrenergic receptors (β 2 AR) in lipid rafts in cardiac, vascular, and bronchial smooth muscle cells [16] [17] [18] ; nicotinic acetylcholine receptor (nAChR) in lipid rafts in pheochromocytoma cells (PC12 cells) [19, 20] ; and μ-but not δ-opioid receptor in lipid rafts in human embryonic (HEK) cells [23] . Toll-like receptor 4 is associated with AC6 in lipid rafts in a murine macrophage cell line [24] , while stomatin-related olfactory protein and AC3 are found in lipid rafts in olfactory cilia [22] . By contrast, AC2 and E prostanoid type 2 receptors are found in nonlipid rafts in mouse bronchial smooth muscle cells [21] . The association of D 1 R and AC5/6 in several cells, including HEK-293 cells, has been reported [12, 25] . However, the AC isoform associated with D 5 R has not been established. In the current study, we investigated whether or not specific AC isoforms are differentially regulated by hD 1 R and hD 5 R in lipid rafts in HEK-293 cells heterologously expressing either hD 1 R (HEK-hD 1 R) or hD 5 R (HEK-hD 5 R) and in human renal proximal tubule (hRPT) cells endogenously expressing D 1 R and D 5 R. Our data indicated that AC 5/6 was differentially distributed in lipid rafts in these renal epithelial cells and their integration in membrane microdomains is important in maintaining basal AC activity and dopamine receptor-mediated signaling.
Methods

Cell treatment
Well-characterized HEK-hD 1 R, HEK-hD 5 R, and hRPT cells were used [12, [26] [27] [28] [29] [30] . The cells, pre-starved in serum-free αMEM medium (SFM) for 1 h, were grown in 100 cm dishes to 90% confluence. The cells were treated for 15 min at 37°C with vehicle, D 1 -like receptor agonist fenoldopam (1.0 μmol/L), D 1 -like receptor antagonist SCH23390 (5.0 μmol/L) alone, or combination of fenoldopam and SCH23390 (SCH23390 added to the cells 5 min prior to the addition of fenoldopam). To disrupt the lipid rafts, the cholesterol depleting reagent methyl−β-cyclodextrin (βCD) was used. The cells were washed once with SFM and then incubated with vehicle or βCD (2%/1 h) at 37°C in SFM [27] . Cholesterol repletion was performed by incubating the cells in a pre-mixed solution containing cholesterol (stock solution in 100% ethanol at 50 mg/mL), 100 μg/mL, and βCD (2%). The cells were also treated with drug combinations: βCD + fenoldopam (βCD added to the cells 1 h prior to the addition of fenoldopam); βCD + cholesterol (mixture added to cells 1 h prior to addition of fenoldopam); and βCD + cholesterol + fenoldopam (βCD + cholesterol mixture added 1 h prior to addition of fenoldopam).
Cell transfection
HEK-hD 1 R, HEK-hD 5 R, and hRPT cells were transfected with vehicle that contained only the transfection reagent and served as control (Con), non-silencing mock-siRNA that consisted of a scrambled sequence and served as another negative control, or siRNA that was specific for a particular AC isoform (AC isoform-siRNA), as described previously [27] . The cells were seeded in 6-well plates at a density of 5 × 10 5 /well at day 1 and then transfected with mock-siRNA, or AC isoform-specific-siRNA at day 2. AC protein and AC activity were determined at day 4. To measure AC activity, the cells were seeded in 12-well plates at a density of 2 × 10 5 /well at day 1, followed by transfection with AC isoform-specific-siRNA at day 2; cAMP concentration was measured at day 4 using a cAMP direct immunoassay kit.
Subcellular fractionation
To prepare lipid and non-lipid rafts, the cells, pre-treated with vehicle (control), fenoldopam (1 μmol/L, 15 min), or βCD 2% at 37°C, were subjected to sucrose density gradient centrifugation, using a detergentfree protocol, as described previously [12, 27] .
Measurement of cAMP accumulation
To measure cAMP accumulation the samples were prepared as described previously [12, 28] . HEK-hD 1 R, HEK-hD 5 R, or hRPT cells were seeded into 12-well plates (2 × 10 5 cells/well) in complete culture medium. When the cells had grown to 90% confluence, they were incubated for 20 min at 37°C with (0.2 mL/well) MHI medium [αMEM serum-free medium, HEPES (10 mmol/L), isobutylmethylxanthine (IBMX, 1 mmol/L), and ascorbic acid (100 μmol/L)]. The cells were then treated with vehicle (MHI medium) or fenoldopam (1 μmol/L) and other drugs diluted in MHI medium (vehicle or drug volume = 50 μL/well) for 10 min at 37°C. The reactions were stopped by adding 0.25 mL of 0.2 N HCl to each well. The cells, collected by scrapping, were transferred into labeled microcentrifuge tubes and centrifuged at 2000 ×g for 5 min. The supernatants were obtained and cAMP was measured using a cAMP immunoassay kit, and expressed as pmol/mg protein/min which was later converted to % change of control.
Co-immunoprecipitation and immunoblotting
To determine the association of D 1 R or D 5 R with specific AC isoforms, co-immunoprecipitation experiments were performed, as described previously [12] . HEK-hD 1 R and HEK-hD 5 R cells were treated with vehicle, fenoldopam (1 μmol/L), SCH23990 (5 μmol/L, added 5 min prior to the addition of fenoldopam), or the combination of fenoldopam and SCH23390 for 10 min. The cells were lysed in MBST buffer and equal amounts of cell lysate proteins (500 μg) were mixed with a polyclonal anti-AC5/6 antibody and incubated at 4°C overnight. Protein A/G beads (30 μl) were added to each sample with rocking for 2 h at 4°C on the next day. The immune complexes were washed 3 × with cold PBS. The bound proteins were eluted by the addition of Laemmli buffer (20 μl) and boiled for 5 min. The samples were subjected to immunoblotting with mouse monoclonal anti-Myc (for hD 1 R) or anti-V5 (for hD 5 R) antibodies, as indicated. Normal rabbit IgG was used as a negative control. The immunoreactive bands were semi-quantified by densitometry [12, 27] .
Statistical analysis
Data are expressed as mean ± standard error (SEM). Significant differences between two groups were determined by Student's t-test. Significant differences among more than 2 groups were determined by one-way factorial ANOVA, followed by Tukey's post-hoc test; P b 0.05 was considered significant.
Results
AC isoform mRNA profile in human kidney cells
The first aim of our studies was to determine the endogenous mRNA expression of AC isoforms in untransfected HEK-293 and hRPT cells using the primers listed in Table S1 . We found that AC3, AC5, AC6, AC7 and AC9 mRNA were expressed in HEK-293 and hRPT cells (Fig. 1) . The endogenous expression of AC2, AC4, AC5/6, and AC9 has been reported in some but not all HEK-293 cell lines [31, 32] . Sequencing of the mRNA products confirmed the identity of these AC isoforms (Table S2) , except for AC2 and AC4. Band B under AC2 mRNA (Fig. 1 ) was a chromodomain helicase DNA binding protein 8. The apparent expression of AC4 mRNA in HEK-293 cells was not confirmed by sequencing because it was not expressed in hRPT cells. AC8 mRNAs was not found in either human kidney cell line (HEK293 and hRPT). The AC mRNA profile in hRPT cells differed from rat RPT cells, which expressed AC2 in addition to AC3, AC6, AC7, and AC9; AC5 was found in hRPT but not in rat RPT cells [9, 33] , indicating species specificity; AC8 mRNA was not found in either human or rat RPT cells but may be minimally expressed in HEK cells. AC1 gene expression was not studied in human renal epithelial cells because this gene is expressed mainly in brain [4] .
Distribution of AC isoforms in lipid and non-lipid raft microdomains
HEK-hD 1 R, HEK-hD 5 R, and hRPT cells have been characterized in our previous reports [12, [26] [27] [28] [29] [30] . We now report the distribution of AC isoform proteins in lipid and non-lipid rafts, using sucrose gradient fractionation samples from these cells. Among the AC isoforms only AC5/6 protein (using an antibody that recognizes both AC5 and AC6) was expressed mainly in lipid rafts in these kidney cells, in agreement with the previous reports [13, 14, 16, 17, 23] ( Fig. 2A and B , upper panels). In the basal state, more AC5/6 was distributed in lipid rafts than in nonlipid rafts and to a greater extent in HEK-hD 1 R cells (84.5±2.3% of total density units, DU) than HEK-hD 5 R cells (69±3.1% total DU) (P b 0.05, n = 4, ANOVA) ( Fig. 2A) . In HEK-hD 1 R cells, AC5/6 was concentrated in lipid raft fraction 4 but, in HEK-hD 5 R cells, AC5/6 was distributed in fractions 3-6 in lipid rafts and fractions 7 and 8 in non-lipid rafts, indicating that the concomitant expression of a specific receptor may alter AC localization in membrane microdomains. In hRPT cells, basal AC5/6 protein profile was similar to that observed in HEK-hD 1 R cells, in which AC5/6 was mainly concentrated in lipid raft fraction 4 (66.6 ±2.2% total DU) (Fig. 2B) . In HEK-hD 1 R cells, fenoldopam increased AC5/6 in lipid raft fractions 3 and 4 (+17.2±3.9% change from control) and decreased AC5/6 in non-lipid rafts (−47.3±5.3% change from control) (P b 0.05, n = 4, ANOVA) ( Fig. 2A) . By contrast, in HEK-hD 5 R cells, fenoldopam had little effect on AC5/6 in lipid rafts (−6.3±1.7% change from control) but increased the expression of AC5/6 in non-lipid raft fractions 8 and 9 (+ 67.1±20.5% from control, P b 0.05, n = 4) ( Fig. 2A) . In hRPT cells, fenoldopam increased AC5/6 protein in lipid rafts in fractions 4 and 5 (*P b 0.05, n = 5, ANOVA) but had little effect on AC5/6 expression in non-lipid rafts (+ 14.9±13.5% of control) (Fig. 2B) , which seems to be the algebraic sum of that found in HEKhD 1 R and HEK-hD 5 R cells.
AC3 protein was also present in lipid and non-lipid rafts in HEKhD 1 R, in agreement with the previous reports [13, 14, 23] , and hRPT cells, but present only non-lipid rafts in HEK-hD 5 R cells, supporting the aforementioned notion that the concomitant expression of a specific receptor may alter AC localization in membrane microdomains. Fenoldopam decreased AC3 protein in lipid rafts in HEK-hD 1 R and hRPT cells but had no effect in HEK-hD 5 R cells (Fig. 2C) .
AC7 protein was expressed mainly in non-lipid rafts and minimally expressed in lipid rafts in both HEK-hD 1 R (12.1± 0.8%) and HEK-hD 5 R cells (13.3±4.1% of total DU) but was diffusely distributed in lipid rafts (fractions 3-6) (29.4±5.4% total DU) and non-lipid rafts (fractions 7-12) in hRPT cells (Fig. 2D ). Fenoldopam had little or no effect on AC7 protein in HEK-hD 1 R and HEK-hD 5 R cells but shifted all of AC7 in lipid rafts to non-lipid rafts in hRPT cells.
AC9 was found mainly in non-lipid rafts and its membrane distribution was not affected by fenoldopam in HEK-hD 1 R, HEKhD 5 R, and hRPT cells (Fig. 2E ). The finding that the AC7 and AC9 distributions in lipid and non-lipid rafts and response to fenoldopam are similar in both HEK-hD 1 R and HEK-hD 5 R cells, unlike that found for AC3 and AC5/6, indicates that the concomitant expression and response to agonist stimulation of a specific GPCR, D 1 R and D 5 R in this instance, is isoformspecific.
Effect of βCD on AC5/6 distribution
βCD, a cholesterol-depleting reagent, has been used to determine the effect of the disruption of lipid rafts on the distribution of proteins in cell membranes [16] [17] [18] [19] [20] 23] . The cells were treated with βCD (2%) at 37°C for 1 h, and the lysates were subjected to sucrose gradient centrifugation as in the previous experiments [12, 27] (Fig. 3A) . Similar to those shown in Fig. 2B , in the basal state, AC5/6 was distributed to a greater extent in lipid than non-lipid rafts in HEK-hD 1 R and hRPT cells, while in HEK-hD 5 R cells AC5/6 was distributed in fractions 3-6 in lipid rafts and fractions 7-9 in non-lipid rafts (Fig. 3A) . In HEK-hD 1 R and HEK-hD 5 R cells, βCD did not alter the membrane distribution of AC5/6 but decreased the molecular size of AC5/6 in lipid rafts in HEKhD 1 R cells, indicating that the presence of a particular protein in the more buoyant sucrose gradient fractions does not necessarily indicate presence in lipid rafts. By contrast, βCD shifted all AC5/6 to non-lipid rafts in hRPT cells.
To determine if the change in molecular size of AC5/6 in HEK-hD 1 R cells caused by βCD was related to deglycosylation, the cell lysates were incubated with N (PNG-F)-glycanase, O-glycanase, or sialidase and then probed with specific polyclonal anti-AC5/6 antibodies. The molecular size of AC5/6 in vehicle-treated cells was 160 kDa and was not affected by PNG-F alone but decreased to 120 kDa following treatment with the combination of PNG-F, O-glycanase, and sialidase A (Fig. S1) . Therefore, the disruption of lipid rafts with βCD may cause AC5/6 deglycosylation in HEK-hD 1 R cells.
We also studied the association of Cav-1, a lipid raft marker protein, with AC5/6 in hRPT cells; similar studies in HEK cells were not performed because Cav-1 is not expressed in some HEK-293 cells, including ours [12, 16, 34, 35] , although it may be present in other HEK-293 cell lines [33] , albeit minimally [36] . In hRPT cells, the D 1 -like receptor agonist fenoldopam increased the association of AC5/6 protein with Cav-1 (147.5 ± 17.2 DU vs. control 70.3 ± 12.6 DU) (P b 0.05, n = 4, ANOVA) (Fig. 3B) , supporting the finding that fenoldopam increased AC5/6 protein in lipid rafts ( Fig. 2A) . Cav-1 has been reported in hRPT cells [27, 29] which can form caveolar membranes [14, 17] . The stimulatory effect of fenoldopam was blocked by the D 1 -like receptor antagonist Sch23390, indicating specific effect on D 1 -like receptors. Fig. 1 . mRNA profiles of adenylyl cyclase (AC) isoforms in human kidney cells. mRNA was extracted from untransfected HEK-293 and hRPT cells from normotensive subjects using the RNeasy RNA Extraction Kit (Qiagen). RT-PCR was performed, as described previously [9] . The sets of primers (A and B) used for human AC isoform mRNA detection are shown in Table S1 , supplementary file.
Association of AC isoforms with specific dopamine receptor subtypes
The GPCR coupling to specific AC isoforms has been reported [16] [17] [18] [19] [20] [21] [22] [23] [24] . We, therefore, determined if D 1 R and D 5 R colocalize with AC5/6 (Fig. 4A) . Fenoldopam promoted the co-localization of hD 1 R with AC5/6 and stimulated cAMP accumulation in HEK-hD 1 R cells at 15 min that became markedly attenuated at 60 min. Fenoldopam also promoted the co-localization of D 5 R with AC5/6 and cAMP production in HEK-hD 5 R cells but to a lesser degree than that observed for hD 1 R in HEK-hD 1 R cells.
The D 1 -like receptor agonist fenoldopam promoted the interaction of 75-kDa-D 1 R with AC5/6 (41.9 ± 4.1 vs. control 15.1 ± 3.5 DU) (P b 0.006, n = 4, ANOVA) in HEK-hD 1 R cells (Fig. 4B, left graph) , while the 45-kDa-but not the 60-kDa-D 5 R interacted with AC5/6 (76.2 ± 9.7 DU vs. control 12.0 ± 2.1 DU) (P b 0.005, n = 4, ANOVA) in HEK-hD 5 R cells (Fig. 4B, right graph) . In addition, D 1 R interacted with AC3 (Fig. 4C) ; D 5 R did not interact with AC3 in HEK-D 5 R cells (Fig. S2, supplementary file) , in agreement with the inability of fenoldopam to alter the non-lipid raft distribution of AC3 in HEK-hD 5 R cells. The interaction of hD 1 R and hD 5 R with AC5/6 and the interaction of D 1 R with AC3 were prevented by the D 1 -like receptor antagonist SCH23990, indicating that the interaction was specific to D 1 R and D 5 R (Fig. 4B and C) . There was interaction between AC4 and D 1 R and AC4 and D 5 R (Fig. S3, supplementary file) . However, the association of D 5 R but not D 1 R with AC4 was reversed by the D 1 -like receptor antagonist SCH23990. We also found that D 1 R interacted with AC9 (Fig. S4, (Fig. 4D) ; control D 5 R was designated as the control for all the experiments in Fig. 4. 
Differential effects of βCD on AC activity in kidney cells
cAMP accumulation was measured in whole cell lysates following drug treatment. Basal cAMP accumulation was greater in HEK-hD 5 R cells (120 ± 11 pmol/mg protein/min) than in HEK-hD 1 R cells (71 ± 4 pmol/mg protein/min) (P b 0.003, n = 4, ANOVA). Fenoldopam markedly increased cAMP accumulation in both cell lines (Fig. 5A and Table 1 ). However, the percent (not absolute) response to fenoldopam was greater in D 1 R (183 ± 22% of control = 100 ± 4.0) than in D 5 R (140 ± 4.8% of control = 100 ± 3.0). The disruption of lipid rafts with βCD decreased basal and fenoldopam-stimulated AC activity by (Fig. 2C) , AC7 (Fig. 2D) , and AC9 (Fig. 2E) .
90% in both cell lines (4 ± 1.6 pmol/mg protein/min in HEK-hD 1 R cells and to 15 ± 4.6 pmol/mg protein/min in HEK-hD 5 R cells), indicating that lipid rafts keep the AC enzyme in an active state in HEK-293 cells (Table 2 ). Cholesterol repletion partially restored AC activity but at levels that were still below control levels (32.4 ± 7.0 pmol/mg protein/min, HEK-hD 1 R and 39.1 ± 7.7 pmol/mg protein/min, HEKhD 5 R cells, vs. βCD treatment and control) (P b 0.05, ANOVA). AC accumulation was also measured in lipid and, non-lipid rafts following drug treatment and sucrose gradient centrifugation. Fenoldopam markedly increased AC activity in lipid rafts in HEK-hD 1 R (Fig. 5B ) and HEK-hD 5 R (Fig. 5C ). The increase in AC activity occurred mainly in lipid rafts in HEK-hD 1 R cells similar to our previous report [12] . AC activity in response to fenoldopam was greater in HEK-hD 1 R (512 ± 47 pmol/mg/min) than in HEK-hD 5 R cells (132 ± 9.1 pmol/mg/min). However, AC activity was greater in non-lipid rafts in HEK-hD 5 R than in HEK-hD 1 R cells. In hRPT cells, basal cAMP accumulation was very low (0.04 ± 0.003 pmol/mg protein/min), relative to HEK-hD 1 R and HEK-hD 5 R cells. βCD treatment increased cAMP accumulation 6.8 ± 0.5-fold (0.29 ± 0.05 pmol/mg protein/min) (P b 0.001, n = 4, ANOVA) (Fig. 5D) , the opposite of the response observed in HEK-hD 1 R and HEK-hD 5 R cells. Cholesterol repletion restored the cAMP accumulation close to basal levels. Fenoldopam markedly increased cAMP accumulation (120 ± 0.6-fold) that was decreased by βCD treatment and partially restored by the addition of cholesterol. Therefore, caution is needed in translating studies in embryonic kidney cells (HEK) to adult RPT cells.
Effect of siRNA-mediated silencing of specific AC isoforms on AC activity
siRNAs against specific AC isoforms were used to determine which AC isoform contributed to hD 1 R or hD 5 R signaling. Silencing the gene expression of AC3, AC5/6, AC7, and AC9 decreased the AC isoform protein expression: 70% for AC3, 50% for AC5/6, 80% for AC7, and 80% for AC9 in HEK-hD 1 R cells (Fig. 6A) . Silencing of a single AC isoform gene with an AC isoform-specific siRNA (AC3, AC5/6, AC7, and AC9) partially decreased the fenoldopam-induced increase in AC activity to similar degrees in HEK-hD 1 R cells and HEK-hD 5 R cells (Fig. 6B) . These studies show that the failure of fenoldopam to alter the lipid and non-lipid raft distribution of AC7 and AC9 or their co-immunoprecipitation with D 1 R or D 5 R did not preclude their involvement in cell signaling. Indeed, silencing multiple AC isoform genes with AC3-, AC5/6-, and/or AC7-specific siRNA augmented their ability to decrease the fenoldopammediated increase in AC activity (60 ± 2.8% of mock-siRNA + Fen) relative to the silencing C5/6 gene (73.4 ± 2.1% of mock-siRNA) in HEK-hD 1 R cells (P b 0.001, n = 4, ANOVA) (Fig. 6C) .
To further confirm the effect of AC5-specific siRNA and AC6-specific siRNA on AC activity, the effect of only AC5-specific siRNA, only AC6-specific siRNA, or their combination were studied. Silencing AC5, AC6, or both had no effect on basal AC activity compared with mock-siRNA in either HEK-hD 1 R or HEK-hD 5 R cells, but the basal level of AC activity was greater in HEK-hD 5 R than in HEK-hD 1 R cells (Fig. S5 , supplementary file), in agreement with previous reports [37, 38] . Silencing the AC5 gene reduced the fenoldopam-stimulated AC activity to almost the same extent in HEK-hD 1 R and HEK-hD 5 R cells (Fig. 6D ), in agreement with previous reports [37, 38] . By contrast, silencing the AC6 gene impaired the ability of fenoldopam to increase AC activity to a greater extent in HEK-hD 1 R than in HEK-hD 5 R cells (P b 0.05, ANOVA). Silencing both AC5 and AC6 genes did not decrease further the effect of either AC5 or AC6 depletion on fenoldopam-mediated increase in AC activity in HEK-hD 1 R cells; however, silencing both AC5 and AC6 caused a lesser impairment in the ability of fenoldopam to increase AC activity, similar to that caused by AC6-specific siRNA alone, in HEK-hD 5 R cells (P b 0.05, vs. siAC5 + 6-D 1 R, ANOVA) (Fig. 6D) . These results could be taken to indicate that AC5 is important in the agonist response of both D 1 R and D 5 R while AC6, independent of AC5, is also involved in the positive agonist response of D 1 R. AC6 may be needed with AC5 to abet the positive agonist response of D 5 R, in agreement with the colocalization of these AC isoforms in lipid rafts.
Discussion
Several lines of evidence have shown that some AC isoforms are distributed in lipid rafts and coupled to different GPCRs and downstream effectors endogenously expressed in tissues and cells [16] [17] [18] [19] [20] [21] [22] 24, 37] or in over-expression systems [23, 24, 37] . However, the regulation of endogenous AC enzymes in human kidney cells has not been reported. We now report the endogenous AC gene expression profiles in HEK-293 and hRPT cells. There are differences among HEK-293, hRPT, and rat RPT cells in the expression of AC isoforms: 1) AC8 is not expressed in rat RPT and hRPT cells, but minimally expressed in HEK-293 cells; 2) AC5 is expressed in HEK-293 and hRPT cells but not in rat RPT cells; and 3) AC2 is expressed in rat RPT cells but not in HEK-293 or hRPT cells [9, 33] .
There are other novel findings in the current studies. First, the distribution of endogenous AC5/6 in lipid and non-lipid rafts in HEK-293 cells is affected by the heterologous expression of D 1 R and D 5 R. Second, the D 1 -like receptor agonist fenoldopam increases AC5/6 protein in lipid rafts and decreases it in non-lipid rafts in HEK-hD 1 R cells, increases AC5/6 in non-lipid rafts only in HEK-hD 5 Lipid rafts are dynamic cholesterol-and sphingolipid-enriched structures that play an important role in organizing signal transduction cascades [13, 14, 38] . The extent by which a given GPCR regulates an AC isoform may depend on its plasma membrane localization [14, 37] . For example, the β 2 adrenergic receptor and AC6 are localized with caveolae in cardiac myocytes, which allow the preferential stimulation of AC6, whereas the prostanoid EP2 receptor, which is distributed outside the caveolae, is coupled to AC6 with far less efficiency [21, 38] . The μ-opioid receptor (μ-OPR), but not δ-OPR, is localized in lipid rafts and is more sensitive than δ-OPR to cholesterol depletion [23] . In the current studies, we found that endogenous AC5/6 protein is concentrated in lipid raft fraction 4 in HEK-hD 1 R while AC5/6 protein is diffusely expressed in lipid raft fractions 2-6 in HEK-hD 5 [12] . Indeed, the maximum fenoldopamstimulated AC activity is greater in HEK-hD 1 R than in HEK-hD 5 R, in agreement with a previous report [42] .
βCD is widely used to disrupt lipid rafts [15] [16] [17] [18] [19] [20] [21] [22] . The disruption of lipid rafts with βCD in HEK-293 cells did not alter the lipid raft fraction 4 localization of AC5/6 but shifted its expression to a lower molecular size from 160 kDa to 120 kDa in HEK-hD 1 R cells, indicating that AC5/6 protein was not sensitive to cholesterol extraction in HEK-293 cells but was sensitive to cholesterol extraction in hRPT cells, as indicated above. The decreased molecular size of AC5/6 may be due to deglycosylation, in agreement with the reports that AC6 and AC3 are glycosylated proteins [32, 43] . However, we do not know why βCD treatment would have caused AC5/6 de-glycosylation in HEK-hD 1 R cells but not in HEKhD 5 R and hRPT cells.
Both D 1 R and D 5 R are coupled to Gαs while D 5 R but not D 1 R is also coupled to Gα 12/13 [7, 44] . The complex of D 1 R-Gαs-AC5/6 may be less stable than that of the complexes of D 5 R-Gsα/Gα 12/13 -AC5/6 in HEKhD 1 R and HEK-hD 5 R, and D 1 R/D 5 R/G-proteins/Cav-1 in hRPT cells. Although AC5/6 distribution pattern is similar in HEK-hD 1 R and hRPT cells, there is a major difference in that AC5/6 protein completely moved out of lipid rafts in hRPT cells but not in HEK-hD 1 R and HEKhD 5 R cells, following the disruption of lipid rafts, indicating that AC5/6 is sensitive to cholesterol extraction in hRPT cells, in agreement with previous reports [16, 17] . The difference in AC5/6 properties between embryonic (HEK-293) and terminally differentiated (hRPT) cells is another example of cell specificity. It may be because of the presence of Cav-1, which is responsible for the formation of caveolae [10, 17] , in hRPT cells but minimally present or even absent in HEK-293 cells [12, (Fig. 4B) or anti-AC3 antibody (Fig. 4C ). Proteins were eluted from the immunocomplexes and probed with anti-Myc-(D 1 R) (Fig. 4B and C) or anti-V5-(D 5 R) (Fig. 4B) 16, 34, 35] . These data could be taken to suggest that different signaling systems are localized in a specialized subdomain of the plasma membrane to optimize the efficiency of signal transduction [10, 45, 46] . βCD treatment has been reported to stimulate or inhibit AC activity [15] [16] [17] [18] [19] [20] [21] [22] . Cholesterol depletion with βCD augmented isoproterenol-, zinterol-, and forskolin-stimulated accumulation of cAMP in rat ventricular cardiomyocytes [16] . βCD treatment or Cav-1 knockdown in C6 glioma cells also increased isoproterenol-or thyrotropin-stimulated cAMP accumulation [15] . However, the inhibition by nicotine of the forskolin-stimulated AC activity in a pheochromocytoma cell line [19] , and basal and α7 nicotinic receptor-stimulated AC activity in airway epithelial cells were prevented by βCD [20] . βCD treatment increased basal forskolin-stimulated cAMP accumulation in HEK-293 cells transfected with δ-and μ-opioid receptors but blocked μ-but not δ-opioid agonistinduced sensitization of AC activity [23] . In the current studies, we found that the disruption of lipid rafts decreases the basal and agonist- The cell lysates were then subjected to sucrose gradient centrifugation as described in "Methods" [12, 27] . Cell fractions 2-6 and 7-12 were combined as LR (fractions 2-6) and non-LR (fractions 7-12) fractions and cAMP accumulation was measured using a cAMP assay kit and expressed as pmol/mg protein/min. Values are mean ± SEM (n = 4/group). *P b 0.001, vs. others in HEK-hD 1 R or HEK-hD 5 Cell sucrose gradient fractions 2-6 and 7-12 were combined as LR [2] [3] [4] [5] [6] and non-LR [7] [8] [9] [10] [11] [12] fractions. The amount of cAMP in each well was measured using cAMP assay kit. cAMP accumulation was calculated and corrected for total protein (mg/mL) and expressed as pmol/mg protein/min. Values are mean ± SEM (n = 4/group). *P b 0.001, vs. all others in HEK-hD 1 R and HEK-hD 5 (35, 47) . The silencing experiments with siRNA can determine the specific AC isoform effect. We found that AC5 is important in the agonist response of both D 1 R and D 5 R but AC6, independent of AC5, is also involved in the positive agonist response of D 1 R. In contrast, in the case of D 5 R, AC6 may be needed with AC5 to abet the positive agonist response, in agreement with the colocalization of these AC isoforms in lipid rafts. AC3 may also be associated with hD 1 R.
Conclusions
Our results emphasize the key role of lipid rafts in the regulation of D 1 R and D 5 R-Gαs-AC signaling in human RPT cells. The integrated membrane microdomain localization of GPCRs and AC isoforms is important in maintaining basal and dopamine receptor-mediated signaling transduction. These findings also suggest that AC isoform-selective signaling complexes likely contribute to various functional consequences of cAMP elevation in human kidney cells.
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